Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Always true @Stock Doc 28. If DD is sound and not trading blindly, holding and even adding through shakeouts are very rewarding.
I do not believe any changes can occur in the way the company does PR or marketing until there is a management change.
It is easy to see by history that that the company has only had one way of doing things, and that is "no way". They have an ingrained belief, right or wrong, that marketing is wrong.
What is so powerful of the Healgen test kits is that in spite of the lack of PR, share prices will soar. So this is actually an optimistic post.
$PURE has the product SDC tested as an antibiotic in older medical journals and independent of the company. Electrolytically generated silver ions stabilized in citric acid as Silver Dihydrogen Citrate
This was something I researched in medical journals. I have a science background and became interested when ionic gold and other minerals became of interest for several uses from vitamins to antibacterials carried in the bloodstream.
I only uncovered a couple very old studies, independent of the company.
Here is one abstract.
4-Once in the bloodstream, the silver ion then travels to all of the tissues of the body, including the bones (which are extremely difficult to treat with antibiotics because of reduced circulation in the dense bone tissues),16where it attacks and kills a broad spectrum of bacteria, viruses, and fungus while remaining medically benign to human cells.17No side effects of nanosilver have ever been reported to have been toxic to mammals.18,19In 1974 and again in 1976 effective dosage levels of nanosilver were found to be safe for mammalian tissues.203)Ongoing medical research (2003) into Oligodynamic silver has conclusively demonstrated that a)“The smaller the particle of silver, the ....
https://drcarolyndeanlive.com/wp-content/uploads/2018/07/SILVER-REPORT-EDIT.pdf
I have been doing some historical evaluations about the companies mind set on marketing. It is great they are conservative and around for 34 years, but their lack of PR is frustrating.
They want the products to sell themselves. So all we can do is wait for the "Subsequent Events" portion of the overdue filing that should be posted any day. At this time it is a lost cause to expect anything more than this.
In spite of this, sales will be record breaking but this Q's filing is still just when COVID hit and will not portray current sales numbers which should move us to $2,50-5.00 / share.
$PURE'S SDC is a safer, food grade product for which Clorox or Lysol cannot compete.
I am sure by now you read posts and info that SDC is food grade, safer to use, does not have to be rinsed and is an excellent virus killer.
Basically Bleach is chlorine, a salt. Colonies of bacteria become biofilms that formed as protective communities that can become resistant to salts. Salts as an oxidizer, kill cells by contact. If biofilms have grown to resist these attacks they will be unaffected. Chlorine is also a toxic, corrosive and damaging to surfaces it is used on.
Silver metal ions especially with Pure's citrate product and antibiotics as tested in this report, enter cells and breakdown the bacteria internally. Pure's website has a great video on it's mode of action: https://www.purebio.com/technology/silver-dihydrogen-citrate-sdc.htm
It has not been mentioned on this board but Silver Dihydrogen Citrate was even being evaluated at one time for internal medical applications for its Silver Ion.
ARCA is not one MM. It is an exchange that gives brokers more options to handle their transactions.
What is ARCA:
The fully-electronic NYSE Arca trades more than 8,000 exchange-listed equity securities—including listings on Nasdaq and Bats. Traders that use the open, direct, anonymous NYSE Arca Equities platform will make rapid, efficient, electronic executions in multiple U.S. market centers. NYSE Arca’s distinct market structure provides significant transparency, tremendous speed, and both displayed and dark liquidity. NYSE Arca Equities Members also get access to innovative order types, aggressive pricing, ultra-low-latency, opening and closing auctions, and other NYSE markets
https://www.nyse.com/publicdocs/nyse/markets/liquidity-programs/arca_mm_orientation.pdf
Therefore as an ECN (electronic communication network), NYSE ARCA is where market makers do their jobs, which can be algorithmic or work as floor traders.
ARCA is a virtual exchange that works with these market makers and uses a rebate structure that works by paying for orders, thus adding liquidity.
The exchange charges a fee for removing liquidity. This is how liquidity is created, by encouraging orders that are outside of the current market price, therefore not immediately executable and basically making them limit orders vs market orders. These orders stay in what is called the "book" and are filled as any limit order would be, when the price of the security moves and triggers them.
Using ARCA or other exchanges gives your broker a number of options. Your order can be sent directly to an ECN/exchange like NYSE ARCA, sent to a market making firm like GTSM, or the broker uses an in house service to execute your trade.
Brokerages must disclose what they do with orders. For example Etrade's disclosure is here: https://content.etrade.com/etrade/powerpage/pdf/OrderRouting11AC6.pdf
These resistance levels have been anticipated for several weeks.
My original resistance level post from July 10 remains unchanged and has proven accurate.
$1.10 where we are currently being held back is actually a huge ceiling when looking back at historical volume. It is our largest roadblock to higher moves.
$1.25 shows less resistance and with a catalyst should move more easily to $1.40. This point @ $1.26 is current high of year and is therefore proven.
Above $1.40 then generally blue skies with smaller resistance in the $1.60's
$ABMC historical high is January 1998 at $6.125 and it looks like it is possible to move through this if record revenues is disclosed.
Hard to believe but we have to go back to 1999-2000 to see why we have resistance at these levels and it becomes very clear and validates how much technicals can help in trading.
It has been confirmed that without the volume we expect from record earnings announcements that these lower price resistance areas cannot be taken for granted.
TheRainbow
It does take patience to hold a position in a company like $ABMC that has been in consolidation for two weeks while other, promoted, moves are happening all around us.
I had three scanner alerts on HTBX in the .90's just the days before it broke out. The thought is always: What if I moved my position from ABMC to HTBX tripled my funds and came back to buy double or triple my ABMC.
Unfortunately, it always works out in hindsight, but not so much in reality. So acting professionally, if we trust the DD of an IMMINENT PR, then I do not mind the ups and downs.
I did unload what I thought was dead weight holdings to bring into ABMC only to see them move up 20-70%. Now that hurts. But the thinking remains the same, hold on to what you have confidence in and jettison the rest and do not follow wishful thinking.
It would be illegal for a CEO to directly hold back a late filing to allow others to buy in "cheap" or on expected subsequent event announcements.
Therefore, it is not probable that these are the reasons for the release to be held back.
Years ago when traders had an easier direct contact with MM's they used to be able to have shares moved or transferred into their accounts in exchange for services such as promotion and marketing, or from direct investments without having to wait for certificates to be transferred, etc. This gave them immediate access to the shares so they could be sold/cash out.
However, there was no way it was being done in obvious 100 share lots on a thinly traded ticker, so I agree, this is weird.
There are many who understand and agree with you. But this next expected run on current and immediate future sales should more than make up for current managements way of thinking, as you also know.
Your clarification on some of the companies history validates a few of my own thoughts and questions.
It has not been mentioned that tax season ended yesterday. I'll understand them for being overworked. This year is very unique.
The company? Well, they are doing all they know how to do.
Not much to dig up from a company that does not promote themselves - EVER
$ABMC passed an FDA inspection on
https://fdahealthnews.com/stories/513136430-fda-update-june-facility-inspection-results
Oh I believe you are seeing what you want to see! (joke). I see it mentioned by many others.
I am like One11, just have to figure it out. Actually I have been wanting to ask for several days, but now I know I am not alone.
I use ThinkorSwim / TD Ameritrade for Level 2
I look for ARCA whenever mentioned, never appears. I'll do some homework to learn why. But would appreciate if anyone else knows, to save me time.
I am seeing consolidation across MANY of my COVID plays. But the $ABMC chart is truly the strongest.
ARCA does not appear in ToS lev2 either.
Agree 100%.
While doing DD, I came across a doctor in Los Angeles that was using the Healgen test and he stated that it was being used by Los Angeles county.
I could not confirm this so did not mention it. Confirm Biosciences has the west coast distribution territory and are described as a very large Healgen distributor.
I think the three of us are saying the same thing, perhaps using different terms. I apologize for not reading John's post clearly and not being as conscientious as I could have been in my reply.
I reread John's first post and agree that when COVID subsides ("cure" as he states) and the economy improves, $PURE's sales will decline, as most COVID stocks, and thus share price may decline.
And fundamentally, today's market should not be reaching weekly highs because sales, employment, COVID-19 is affecting most of the economy. So currently $PURE should be near highs and the market down.
However, the market is acting kinda crazy reaching highs while COVID is strong. But still, COVID stocks should also be at their highs.
Hope this clarifies. Yes, this is what message boards are for. A place to learn from others.
I just added large at $1.35. Let's prove your week analysis to be true.
Good luck to you to. Yahoo conversations has no new info for us either so we definitely are due.
@sublover, my last post disagrees that fundamentally strong COVID-19 companies are sympathy plays. I have many, many examples of this being a truth.
And yes, we have no control over what larger shareholders (not the insiders you mention) do. Perhaps they are moving cash around or some are getting margin calls and have to sell positions in profitable trades. All speculation.
(And I think it was your posts that initially drove share price up)
Lets get ready for the next run up. I'll be loading up again. I did take profits at $2.00 so my curent shares are free.
JK, I am in half a dozen COVID-19 trades and they are all in strong up trends, especially this past week. I do not even look at the rest of the market because of the strength of my solid COVID involved companies.
These fundamentally solid COVID companies may show some volatility, but 100% of my holdings are in solid up trends or consolidation.
Why? Each of them, including $PURE, is showing record revenues and should increase in share price through 2020.
One issue investors should be cautious about is that a few companies are taking advantage of these share price increases to dilute. This hurt their upward movements. Since $PURE has not filed a share increase it is doubtful they are diluting.
I see no technical reason for $PURE to fall through the floor as it has.
The only possibility is a large seller, or something happening with the fundamentals of the company. I hope they take advantage of their good fortune, albeit due to poor circumstances, to do a complete company makeover.
TheRainbow
Maybe the floor dropped out because you and I have not posted here for awhile ;-}
I am surprised support was lost at $1.80 and actually bothered by it because I am such a supporter of $PURE products.
I started to add to my position in the $1.40's during those volatile days before support was lost at $1.80.
The floor dropping out completely surprised me and I can only explain it by lack of interest due to no updates since we ran over $2.00. I may add here or watch it another day or so.
PR coming?? Perhaps with this volume increasing.
$AYTU hurt their own business by trying to sell the Chembio test over the Healgen test.
From an earlier post, Then this happened:
$ABMC COVID-19 Rapid Test outperforms the $AYTU partner- $CERC, Chembio Diagnostic Systems DPP Covid-19 IgM/IgG System test.
This was a post I made back on June 9, 2020 and it is confirmed today.
FDA Revokes Emergency Use Authorization for Chembio Antibody Test
https://www.prnewswire.com/news-releases/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-for-chembio-antibody-test-301078324.html
The Healgen test is listed along with
roche and the Mount Sinai Hospital Clinical Laboratory COVID-19 ELISA Antibody Test. These are the only three EUA Authorized Serology COVID-18 Test Performance kits from a group of sixteen EUA authorized Serology tests. Dated as of 2020-06-04.
The Healgen COVID-19 IgG/IgM Rapid Test Cassette which @ABMC distributes is the only one that does both COVID-19 IgG/IgM.
https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance
TheRainbow
$ABMC has the distribution region for Healgen/Orient Gene COVID-19 test kit with the greatest COVID-19 problems and is the official distributor for the eastern seaboard and South America, $AYTU handles midwest and Rocky Mountains and Confirm Biosciences a private company handles the west coast, Hawaii and Alaska.
Fantastic outlook for $ABMC! Thanks for the nice summary @tomj1.
Updated Resistance levels for $ABMC.
$ABMC is chewing through shares and resistance below $1.25
Above $1.25 less resistance and should move more easily to $1.40 with $1.35 showing a bit more resistance..
Above $1.40 then generally blue skies.
$ABMC historical high is January 1998 at $6.125 and it looks like it is possible to move through this if record revenues is disclosed.
With the volume we expect due to a record sales announcement, these lower price resistance areas may not be a huge issue, but as we learned, they cannot be taken for granted.
TheRainbow
My notes on $TOMDF from April while adding to $ABMC:
20-04-28 .08785 Voting on reverse split and bloated authorized shares 100:1
I can certainly feel it.....
"You can feel it once again...it is that palpable. She wants to run again"
$ABMC only 15,229,338 shares available to trade.
Authorized Shares 50,000,000 05/12/2020
Outstanding Shares 35,847,093 05/12/2020
$ABMC shares recorded with SEC
Stuart Sternberg Amount beneficially owned: 2,428,671 shares Percent of class: 7.4% of 32,680,984 outstanding shares reported September 30, 2019
John J. Moroney Amount beneficially owned: 2,481,608 Percent of class: 7.6% 4/27/2020
John J. Moroney Amount beneficially owned: 3,457,011 Percent of class: 11.4% 10/24/2016
MP Biomedicals LLC Amount beneficially owned: 4,738,601 shares Percent of class: 18.2% ownership of ABMC 03/03/2016
Davis Chaim Buy 528,571 03/02/2020
Davis Chaim Buy 500,000 01/23/2019
Misc Directors 366,100
Totals- 13,600,562 shares held 41.6%
Plus unoffical ahares held by others on this board over 5%
Only 53.4% 19,142,347 shares left to trade.
Open to corrections or additions.
These placement price levels fit in well with my price DD. I never dug deeper than the recent filings of the past few years so this clears some things up.
$ABMC traded at the $1.10 level from 2000-2007 which is the majority of the historical volume on my charting. Throw in a 2.5 mill placement and I could definitely see it.
I have a small volume spike at $3.50-$4.25, but is relatively small compared to recent numbers so I did not mention it, but it is there. May have been shareholders selling down to the placement price.
My charts only go back as far at 1997 but by extrapolation, the .75 conversions made some rich investors because it seems $ABMC was trading in the $5.00's. Not clear to me how this arrangement was made.
As a side note. This charting, showing the history of $ABMC, makes it clear that some very long holders will be taking profits from purchases they made over the past decade. So when they are gone new company highs are on the way.
The current float is only 19 mil shares.
Thanks @bk1287. I updated the text from the post which was made a couple weeks ago.
We are $1.10 x $1.17 = $.07 spread which as been happening more and more frequently. Things are happening.
OK, I am clear. In any case he did check in, so hope he takes advantage of all the DD you and @AdamS007 brought the board, especially early on when I started my DD. @Willymon put in a lot of work too.
Thanks for all your hard work.
Resistance price levels for $ABMC are being confirmed. Don't push to hard to blow past these areas or MM will be forced to bring prices back down again in the near future to pick up stop losses, fill gaps etc.
$ABMC historical high is January 1998 at $6.125 and it looks like it is possible to move through this if record revenues is disclosed.
Hard to believe but we have to go back to 1999-2000 to see why we have resistance at these levels and it becomes very clear. I should have taken this more seriously and verified earlier.
$1.10 where we were held for a period of time was the had very historical and held us back a huge ceiling. It will become support as we begin to move up and past this area.
$1.25 less resistance and should move more easily to $1.40. This point @ 1.26 is current high of year and is therefore proven.
Above $1.40 then generally blue skies.
$ABMC historical high is January 1998 at $6.125
With the volume we expect due to record volumes these lower price resistance areas may not be a huge issue, but as we learned, they cannot be taken for granted.
TheRainbow
@SPORTYNORTY by coincidence I am in or watching a few companies ORCA is in and we are both making bank on those buys. When he checked in here a couple weeks ago, I was curious to know what his intentions were because $ABMC is just to obvious to pass up.
Let me say it again "$ABMC is just to obvious to pass up".
$ABMC new reality is Volatility which is increasing as float is reduced. Look at the .05 spread 1.10 / 1.15 and how easy it gapped upwards towards $1.20 and more easily gapped back down to $1.13.
That is why I gave you the conservatively estimated float numbers and price resistance levels.
With good news we can see $.20+ gaps on the run up.
Most needed item during this COVID-19 time
Best testing kit
Lowest float
Best investors
GLTA next week.
Resistance levels for $ABMC.
$ABMC historical high is January 1998 at $6.125 and it looks like it is possible to move through this if record revenues is disclosed.
Hard to believe but we have to go back to 1999-2000 to see why we have resistance at these levels and it becomes very clear. I should have taken this more seriously and verified earlier.
$1.10 where we are currently being held back is actually a huge ceiling.
$1.25 less resistance and should move more easily to $1.40. This point @ 1.26 is current high of year and is therefore proven.
Above $1.40 then generally blue skies.
$ABMC historical high is January 1998 at $6.125
With the volume we expect due to record volumes these lower price resistance areas may not be a huge issue, but as we learned, they cannot be taken for granted.
TheRainbow